I won’t lie to you – it was somewhat startling.
For several years now I’ve been telling you about advances in research of intravenous vitamin C ( intravenous ascorbic acid – IAA) to treat cancer. Sure, there’s been a growing acceptance that vitamin C effectively kills some types of cancer cells. But nothing had prepared me for a sudden flurry of headlines like these:
- “Vitamin C Shows Promise as Cancer Treatment” – Washington Post
- “Vitamin C May be Useful to Treat Cancer After All” – Reuters
- “Final Proof of a Theory” – Daily Record
“Final proof” may be overstating the results of a mouse study. But for whatever reason, this intravenous vitamin C mouse study roared.
Poisoning the bad, sparing the good
The new study was led by Dr. Mark Levine, a National Institutes of Health researcher. NIH also funded the study.
Dr. Levine and his team implanted mice with three types of cancer cells: brain, pancreatic, and ovarian. All three are very aggressive cancers. The intravenous vitamin C slashed cancer cell growth in half.
A HealthDay News report about the study called this “an unexpected use for vitamin C.”
Sure – completely unexpected if you’ve completely ignored existing research such as a 2005 study I told you about in the e-Alert “Cold Case” (9/22/05).
In that study (also led by Dr. Levine) 10 types of cancer cells and four types of normal cells were exposed to high vitamin C levels that could easily be reached intravenously. In five of the cancer cell types, about half of the cells were either killed or apoptosis (cell “suicide”) occurred. Also, intravenous vitamin C exposure nearly completely halted the growth of surviving cells.
Remarkably, the vitamin C left the normal cells alone… they weren’t damaged.
Levine and his NIH team theorized that the high concentration of C prompted the formation of hydrogen peroxide (HP), which is known to kill cells. In this case the healthy cells may have repaired HP damage, but the cancer cells were defenseless.
Spreading the word about intravenous vitamin C
The Press Association summation of the Levine study noted that human trials of intravenous vitamin C are needed “before any thought can be given to using injected vitamin C to fight cancer.”
Those trials are now underway, but I’m pretty sure at least one Pennsylvania patient would strongly disagree about waiting before giving any thought to this therapy.
NBC’s Philadelphia affiliate covered the Levine study by featuring a local doctor – Scott Greenberg, M.D. – and one of the many cancer patients he’s successfully treated with IAA.
At age 59, Arlindo Olivera’s doctors told him that his treatment options had run out. Lung cancer spread to his brain. His condition was hopeless, they said. That’s when Olivera began intravenous vitamin C treatment with Dr. Greenberg. One year later, Olivera is cancer-free.
And Mr. Olivera’s story is not unique. You can find descriptions of several successful IAA case studies in these e-Alerts:
“Just Getting Started” (4/11/06)
“Diamonds in the Rough” (7/3/06)
And you can find tips about locating a practitioner who administers intravenous vitamin C therapy in the e-Alert “Calling Out Around the World” (10/24/06).
I hope you’ll share this with your family and friends. Please help us get the word out that there are promising natural alternatives to chemotherapy and radiation therapy.
Jenny Thompson is the Director of the Health Sciences Institute and editor of the HSI e-Alert. Through HSI, she and her team uncover important health information and expose ridiculous health misinformation, most notably through the HSI e-Alert.
Visit www.hsionline.com to sign up for the free HSI e-Alert.
Latest posts by Jenny Thompson (see all)
- Warning: Scam artists trying to con you out of cash! - October 12, 2016
- Daily 10 minute ritual slashes risk of 5 deadly conditions - October 10, 2016
- Is it safe to eat? Figuring out food expiration dates - October 2, 2016